Trillium Asset Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.66M Sell
84,946
-8,015
-9% -$548K 0.22% 95
2025
Q4
$5.71M Sell
92,961
-16,073
-15% -$872K 0.17% 111
2025
Q3
$6.02M Sell
109,034
-305
-0.3% -$15.9K 0.16% 114
2025
Q2
$4.71M Sell
109,339
-8,641
-7% -$333K 0.13% 124
2025
Q1
$4.67M Buy
117,980
+3,055
+3% +$135K 0.13% 126
2024
Q4
$4.68M Buy
114,925
+38,896
+51% +$1.62M 0.12% 138
2024
Q3
$2.97M Sell
76,029
-238
-0.3% -$9.48K 0.07% 157
2024
Q2
$3.33M Buy
76,267
+4,764
+7% +$230K 0.08% 155
2024
Q1
$3.41M Buy
71,503
+7,448
+12% +$335K 0.09% 152
2023
Q4
$3.02M Sell
64,055
-18,059
-22% -$750K 0.08% 150
2023
Q3
$3.91M Buy
82,114
+8,196
+11% +$447K 0.12% 138
2023
Q2
$4.3M Buy
73,918
+526
+0.7% +$31.6K 0.12% 134
2023
Q1
$5.26M Sell
73,392
-8,956
-11% -$711K 0.15% 109
2022
Q4
$5.8M Buy
82,348
+202
+0.2% +$14.2K 0.18% 112
2022
Q3
$4.98M Buy
82,146
+2,325
+3% +$156K 0.16% 115
2022
Q2
$5.04M Buy
79,821
+577
+0.7% +$37.6K 0.15% 118
2022
Q1
$5.08M Sell
79,244
-4,375
-5% -$293K 0.14% 129
2021
Q4
$6M Sell
83,619
-12,484
-13% -$949K 0.14% 125
2021
Q3
$6.86M Buy
96,103
+7,824
+9% +$617K 0.18% 115
2021
Q2
$7.18M Buy
88,279
+3,616
+4% +$291K 0.2% 109
2021
Q1
$6.39M Buy
84,663
+6,223
+8% +$453K 0.2% 108
2020
Q4
$5.94M Buy
78,440
+686
+0.9% +$44.7K 0.21% 105
2020
Q3
$3.84M Sell
77,754
-14,569
-16% -$822K 0.16% 107
2020
Q2
$4.85M Buy
92,323
+18,650
+25% +$885K 0.21% 103
2020
Q1
$2.59M Buy
73,673
+33,652
+84% +$1.97M 0.14% 132
2019
Q4
$3.5M Buy
40,021
+92
+0.2% +$8.04K 0.16% 134
2019
Q3
$3.39M Buy
39,929
+14,181
+55% +$1.26M 0.16% 132
2019
Q2
$2.71M Buy
+25,748
New +$2.59M 0.13% 146

Other funds holding NGVT

Trillium Asset Management's NGVT Position: Q1 2026 in Review

Trillium Asset Management reduced its Ingevity (NGVT) stake by 8.6% in Q1 2026, selling an estimated $548K and leaving 84,946 shares worth $6.66M. The position accounts for 0.22% of the portfolio, ranked #95.

Trillium Asset Management first reported a position in NGVT in Q2 2019 and has held it in 28 quarters since. The position peaked at $7.18M in Q2 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Trillium Asset Management held 84,946 shares of Ingevity worth $6.66M as of Q1 2026.
  • Trillium Asset Management sold 8,015 Ingevity shares in Q1 2026, an estimated $548K.
  • Ingevity made up 0.22% of Trillium Asset Management's portfolio in Q1 2026, its #95 holding.
  • Trillium Asset Management first reported a position in Ingevity in Q2 2019 and has held it in 28 quarters since.
  • Trillium Asset Management's Ingevity position peaked at $7.18M in Q2 2021.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Trillium Asset Management's 13F filing for Q1 2026, filed 11 May 2026.